Hi - after class I saw this article on an online database a pharma (Lilly) plans to set up to share names of all outside physicians it makes payments to for consulting, etc
http://www.nytimes.com/2008/09/25/health/policy/25drug.html?_r=1&hp&oref=slogin
This is in advance of a bipartisan bill called the Sunshine Act that would create a national registry of such payments. Part of the transparency trend,
Kim
Subscribe to:
Post Comments (Atom)
1 comment:
I was going to post on the very same article. Its interesting that in order to circumvent official regulations, some of the drug companies are stealing the thunder and creating their own databases and transparency mechanisms. I wonder if the federal regulations are going to be more stringent than the ones the drug companies are submitting to voluntarily.
Post a Comment